About Prism Medico And Pharmacy Limited
Data last updated: 22 December 2025
Prism Medico And Pharmacy Limited is a public limited company based in Kala Amb, Himachal Pradesh, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 22 March 2002, the company has been in operation for over 24 years.
Registered with ROC Himachal Pradesh under CIN L24100HP2002PLC009299. Listed on BSE: 512217.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹6.06 Cr. It is led by directors including Sakshi Laller and Dinesh Kumar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Suketi Road, Kala Amb, Himachal Pradesh, India – 173030.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.27 Cr, a decline of 84.93% compared to the previous year.
The company is associated with 1 brand - Prism Medico.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prismmedico.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressSuketi Road, Kala Amb, Himachal Pradesh, India – 173030
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited has 5 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100HP2002PLC009299, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100HP2002PLC009299 | Current |
| L51109HP2002PLC009299 | Previous |
| U51109WB2002PLC094419 | Previous |
| L51109MH2002PLC206595 | Previous |
| L51109WB2002PLC094419 | Previous |
| L51109PB2002PLC047444 | Previous |
Associated Brands with Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited operates one associated brand: Prism Medico. These brands represent Prism Medico And Pharmacy Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Drugs for multiple therapeutic areas are manufactured through R&D efforts. | prismmedico.in |
Competitors & Alternatives of Prism Medico And Pharmacy Limited
Brands and companies operating in the same space as Prism Medico And Pharmacy Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited operates primarily in the trade sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Trade | ********* | Wholesale Trading | ********* |
Auditor Details of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited is audited by GARG MENDIRATTA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-12-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| GARG MENDIRATTA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-12-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited is currently managed by 6 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sakshi Laller
Also directs:
Prism Medico And Pharmacy Limited, Symbiosis Biolife Llp, Infuze Well Private Limited and 1 more
|
Whole-Time Director | 16 May 2023 | 3 Years 1 Months | Current |
| Dinesh Kumar | Director | 14 Aug 2023 | 2 Years 10 Months | Current |
|
Davender Singh
Also directs:
Prism Medico And Pharmacy Limited
|
Director | 31 Jan 2022 | 4 Years 5 Months | Current |
|
Pardeep Kumar
Also directs:
Prism Medico And Pharmacy Limited
|
Director | 31 Jan 2022 | 4 Years 5 Months | Current |
Financials of Prism Medico And Pharmacy Limited FY 2026 filings available
Prism Medico And Pharmacy Limited reported revenue of ₹2.44 Cr (up 286.68% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2.44 Cr | ₹63.19 Lakh | ₹2.93 Cr | ₹1.27 Cr | ₹8.44 Cr | ₹16.76 Cr | ₹26.89 Cr | ₹36.31 Cr |
| Other Income | ₹2.61 Lakh | ₹1.65 Lakh | ₹12.22 Lakh | ₹17,000 | ₹0 | ₹0 | ₹0 | ₹21.87 Lakh |
| Total Income | ₹2.47 Cr | ₹64.84 Lakh | ₹3.05 Cr | ₹1.27 Cr | ₹8.44 Cr | ₹16.76 Cr | ₹26.89 Cr | ₹36.52 Cr |
| Cost of Materials Consumed | ₹1.57 Cr | ₹44.85 Lakh | ₹2.56 Cr | ₹1.14 Cr | ₹10.55 Cr | ₹21.47 Cr | ₹25.7 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹35.28 Cr |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | -₹1.92 Cr | -₹4.8 Cr | ₹91.38 Lakh | -₹7.61 Lakh |
| Employee Benefit Expense | ₹6.03 Lakh | ₹4.26 Lakh | ₹3.4 Lakh | ₹4.66 Lakh | ₹19.04 Lakh | ₹16.76 Lakh | ₹21.9 Lakh | ₹24.63 Lakh |
| Finance Costs | ₹33,000 | ₹17,000 | ₹71,000 | ₹3,000 | ₹4,000 | ₹2,000 | ₹2,000 | ₹2,000 |
| Depreciation & Amortisation | ₹35,000 | ₹42,000 | ₹52,000 | ₹66,000 | ₹86,000 | ₹1.23 Lakh | ₹1.76 Lakh | ₹2.67 Lakh |
| Other Expenses | ₹40.4 Lakh | ₹21.72 Lakh | ₹46.82 Lakh | ₹18.03 Lakh | ₹11.55 Lakh | ₹9.04 Lakh | ₹11.05 Lakh | ₹75.27 Lakh |
| Total Expenses | ₹2.04 Cr | ₹71.42 Lakh | ₹3.08 Cr | ₹1.37 Cr | ₹8.94 Cr | ₹16.94 Cr | ₹26.96 Cr | ₹36.23 Cr |
| Profit Before Exceptional Items & Tax | ₹42.96 Lakh | -₹6.58 Lakh | -₹2.79 Lakh | -₹10.22 Lakh | -₹49.9 Lakh | -₹17.51 Lakh | -₹6.8 Lakh | ₹29.34 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹42.96 Lakh | -₹6.58 Lakh | -₹2.79 Lakh | -₹10.22 Lakh | -₹49.9 Lakh | -₹17.51 Lakh | -₹6.8 Lakh | ₹29.34 Lakh |
| Total Tax Expense | ₹11.12 Lakh | -₹1.71 Lakh | -₹66,000 | -₹2.59 Lakh | -₹13 Lakh | -₹4.51 Lakh | -₹1.78 Lakh | -₹68,000 |
| Net Profit | ₹31.84 Lakh | -₹4.87 Lakh | -₹2.13 Lakh | -₹7.64 Lakh | -₹36.9 Lakh | -₹13 Lakh | -₹5.02 Lakh | ₹36.96 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹12,000 | ₹2.68 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹31.84 Lakh | -₹4.87 Lakh | -₹2.01 Lakh | ₹2.61 Cr | -₹36.9 Lakh | -₹13 Lakh | -₹5.02 Lakh | ₹36.96 Lakh |
| EBITDA (computed) | ₹43.64 Lakh | -₹5.99 Lakh | -₹1.56 Lakh | -₹9.53 Lakh | -₹49 Lakh | -₹16.26 Lakh | -₹5.02 Lakh | ₹32.03 Lakh |
| Basic EPS | ₹0.53 | ₹-0.08 | ₹0.00 | ₹-0.01 | ₹0.00 | ₹-0.02 | ₹-0.01 | ₹0.61 |
| Diluted EPS | ₹0.53 | ₹-0.08 | ₹0.00 | ₹-0.01 | ₹0.00 | ₹-0.02 | ₹-0.01 | ₹0.61 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹15.61 Cr | ₹15.56 Cr | ₹15.24 Cr | ₹15.39 Cr | ₹12.57 Cr | ₹21.54 Lakh Cr | ₹21.58 Lakh Cr | ₹16.97 Cr |
| Non-current Assets | ₹15.15 Lakh | ₹26.62 Lakh | ₹25.39 Lakh | ₹25.26 Lakh | ₹23.33 Lakh | ₹205,215 Cr | ₹201,935 Cr | ₹10.09 Cr |
| Current Assets | ₹15.46 Cr | ₹15.3 Cr | ₹14.99 Cr | ₹15.14 Cr | ₹12.34 Cr | ₹19.49 Lakh Cr | ₹19.56 Lakh Cr | ₹6.89 Cr |
| Property, Plant & Equipment | ₹2.58 Lakh | ₹2.93 Lakh | ₹3.36 Lakh | ₹3.88 Lakh | ₹4.54 Lakh | ₹5,534.09 Cr | ₹6,773.81 Cr | ₹8.54 Lakh |
| Inventories | ₹6.77 Cr | ₹6.77 Cr | ₹6.77 Cr | ₹6.77 Cr | ₹6.77 Cr | ₹484,662 Cr | ₹4,757.29 Cr | ₹96.16 Lakh |
| Trade Receivables | ₹3.93 Cr | ₹3.58 Cr | ₹3.69 Cr | ₹4.76 Cr | ₹4.88 Cr | ₹13.51 Lakh Cr | ₹18.34 Lakh Cr | ₹3.76 Cr |
| Cash & Equivalents | ₹6.37 Lakh | ₹6.54 Lakh | ₹8.36 Lakh | ₹9.58 Lakh | ₹5.51 Lakh | ₹8,413.29 Cr | ₹11,176 Cr | ₹11.76 Lakh |
| Equity (Net Worth) | ₹15.41 Cr | ₹15.09 Cr | ₹15.14 Cr | ₹15.16 Cr | ₹12.55 Cr | ₹12.93 Lakh Cr | ₹13.06 Lakh Cr | ₹13.15 Cr |
| Equity Share Capital | ₹6.06 Cr | ₹6.06 Cr | ₹6.06 Cr | ₹6.06 Cr | ₹6.06 Cr | ₹606,343 Cr | ₹606,343 Cr | ₹6.06 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹19.99 Lakh | ₹47.17 Lakh | ₹7.07 Lakh | ₹23.17 Lakh | ₹1.74 Lakh | ₹861,612 Cr | ₹852,817 Cr | ₹3.82 Cr |
| Total Liabilities | ₹19.99 Lakh | ₹47.17 Lakh | ₹10.15 Lakh | ₹23.17 Lakh | ₹1.74 Lakh | ₹861,612 Cr | ₹852,817 Cr | ₹3.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹17,000 | -₹1.65 Lakh | -₹50,000 | ₹2.95 Cr | -₹2.38 Cr |
| Investing Cash Flow | ₹0 | ₹0 | ₹0 | -₹2.91 Cr | ₹2.35 Cr |
| Financing Cash Flow | -₹34,000 | -₹17,000 | -₹71,000 | -₹3,000 | -₹4,600 |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹17,000 | -₹1.65 Lakh | -₹50,000 | ₹2.95 Cr | -₹2.38 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹17,000 | -₹1.82 Lakh | -₹1.21 Lakh | ₹4.07 Lakh | -₹2.9 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹28.14 Lakh | ₹7.1 Lakh | ₹50.23 Lakh | ₹1.59 Cr | ₹7.28 Lakh | ₹20.86 Lakh | ₹28.78 Lakh | ₹6.27 Lakh |
| Other Income | ₹21,000 | ₹69,000 | ₹1.67 Lakh | ₹4,000 | ₹1.09 Lakh | ₹35,000 | ₹0 | ₹21,000 |
| Total Income | ₹28.35 Lakh | ₹7.79 Lakh | ₹51.9 Lakh | ₹1.59 Cr | ₹8.37 Lakh | ₹21.21 Lakh | ₹28.78 Lakh | ₹6.48 Lakh |
| Cost of Materials Consumed | ₹21.53 Lakh | ₹4.25 Lakh | ₹45.35 Lakh | ₹85.75 Lakh | ₹1.15 Lakh | ₹15.22 Lakh | ₹23.68 Lakh | ₹4.8 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.69 Lakh | ₹1.19 Lakh | ₹1.2 Lakh | ₹95,000 | ₹1.1 Lakh | ₹1.13 Lakh | ₹1.03 Lakh | ₹1 Lakh |
| Finance Costs | ₹3,000 | ₹2,000 | ₹28,000 | ₹0 | ₹13,000 | ₹0 | ₹0 | ₹4,000 |
| Depreciation & Amortisation | ₹6,000 | ₹6,000 | ₹10,000 | ₹13,000 | ₹3,000 | ₹13,000 | ₹13,000 | ₹13,000 |
| Other Expenses | ₹16.34 Lakh | ₹3.61 Lakh | ₹13.45 Lakh | ₹7.01 Lakh | ₹3.7 Lakh | ₹5.63 Lakh | ₹2.94 Lakh | ₹9.45 Lakh |
| Total Expenses | ₹40.65 Lakh | ₹9.13 Lakh | ₹60.38 Lakh | ₹93.84 Lakh | ₹6.11 Lakh | ₹22.11 Lakh | ₹27.78 Lakh | ₹15.42 Lakh |
| Profit Before Exceptional Items & Tax | -₹12.3 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.07 Lakh | ₹2.26 Lakh | -₹90,000 | ₹1 Lakh | -₹8.94 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹12.3 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.07 Lakh | ₹2.26 Lakh | -₹90,000 | ₹1 Lakh | -₹8.94 Lakh |
| Total Tax Expense | ₹11.78 Lakh | ₹0 | ₹0 | -₹66,000 | -₹1.89 Lakh | ₹6,000 | ₹6,000 | ₹6,000 |
| Net Profit | -₹24.08 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.73 Lakh | ₹4.15 Lakh | -₹96,000 | ₹94,000 | -₹9 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹24.08 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.73 Lakh | ₹4.15 Lakh | -₹96,000 | ₹94,000 | -₹9 Lakh |
| EBITDA (computed) | -₹12.21 Lakh | -₹1.26 Lakh | -₹8.1 Lakh | ₹65.2 Lakh | ₹2.42 Lakh | -₹77,000 | ₹1.13 Lakh | -₹8.77 Lakh |
| Basic EPS | ₹-0.30 | ₹-0.02 | ₹0.00 | ₹0.01 | ₹0.07 | ₹0.00 | ₹0.00 | ₹0.00 |
| Diluted EPS | ₹-0.30 | ₹-0.02 | ₹0.00 | ₹0.01 | ₹0.07 | ₹0.00 | ₹0.00 | ₹0.00 |
| Metrics | FY 2019 |
|---|---|
| Revenue from Operations | ₹54.43 Cr |
| Other Income | ₹29.61 Lakh |
| Total Income | ₹54.72 Cr |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹53.13 Cr |
| Changes in Inventories | ₹10.29 Lakh |
| Employee Benefit Expense | ₹27.09 Lakh |
| Finance Costs | ₹10.73 Lakh |
| Depreciation & Amortisation | ₹38.27 Lakh |
| Other Expenses | ₹82.61 Lakh |
| Total Expenses | ₹54.82 Cr |
| Profit Before Exceptional Items & Tax | -₹9.66 Lakh |
| Exceptional Items | ₹0 |
| Profit Before Tax | -₹9.66 Lakh |
| Total Tax Expense | -₹6.74 Lakh |
| Net Profit | ₹4.02 Lakh |
| attributable to Owners | ₹0 |
| attributable to NCI | ₹0 |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹4.02 Lakh |
| EBITDA (computed) | ₹39.34 Lakh |
| Basic EPS | ₹0.07 |
| Diluted EPS | ₹0.07 |
| Metrics | FY 2019 |
|---|---|
| Total Assets | ₹21.2 Cr |
| Non-current Assets | ₹10.37 Cr |
| Current Assets | ₹10.84 Cr |
| Property, Plant & Equipment | ₹8.91 Cr |
| Inventories | ₹1.39 Cr |
| Trade Receivables | ₹3.13 Cr |
| Cash & Equivalents | ₹40.69 Lakh |
| Equity (Net Worth) | ₹12.91 Cr |
| Equity Share Capital | ₹6.06 Cr |
| Borrowings (Non-current) | ₹0 |
| Borrowings (Current) | ₹2.27 Cr |
| Total Debt (computed) | ₹2.27 Cr |
| Current Liabilities | ₹8.27 Cr |
| Total Liabilities | ₹8.29 Cr |
| Metrics |
|---|
Shareholding Pattern of Prism Medico And Pharmacy Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 25.49%, retail and other public shareholders hold 74.51% of Prism Medico And Pharmacy Limited. The company had 4,295 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 25.49% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% |
| Public | 74.51% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 25.49% | 25.00% | 25.00% |
| Public | 74.51% | 75.00% | 75.00% |
| Promoter change (YoY, %pts) | +0.49 | +0.00 | - |
Charges & Borrowings Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Prism Medico And Pharmacy Limited
View historical data on people associated with Prism Medico And Pharmacy Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Prism Medico And Pharmacy Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Prism Medico And Pharmacy Limited
GSTIN & GST Filing Data of Prism Medico And Pharmacy Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Prism Medico And Pharmacy Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Prism Medico And Pharmacy Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Prism Medico And Pharmacy Limited
MSME Payment Delays by Prism Medico And Pharmacy Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Prism Medico And Pharmacy Limited
Subsidiaries & Group Companies of Prism Medico And Pharmacy Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Prism Medico And Pharmacy Limited with ownership details.
MCA Filings & Documents of Prism Medico And Pharmacy Limited
MCA Filings & Documents of Prism Medico And Pharmacy Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Prism Medico And Pharmacy Limited
Frequently Asked Questions about Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited is an active public limited company in the chemicals and materials sector based in Kala Amb, Himachal Pradesh, India. It was incorporated on 22 March 2002 (24+ years old) and is registered under CIN L24100HP2002PLC009299. Listed on BSE: 512217.
Prism Medico And Pharmacy Limited reported revenue of ₹1.27 Cr for FY 2023 (down 84.93% YoY).
The current directors of Prism Medico And Pharmacy Limited are:
- Sakshi Laller
- Bharat Singh
- Sameer Gupta
- Dinesh Kumar
- Davender Singh
- Pardeep Kumar
The primary industry of Prism Medico And Pharmacy Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Yes. Prism Medico And Pharmacy Limited is listed on BSE with code 512217.
Prism Medico And Pharmacy Limited can be reached at the registered office: Suketi Road, Kala Amb, Himachal Pradesh, India – 173030, or through the website prismmedico.com.